Skip to main content

beta This is a new site, your feedback will help us to improve it.

FOI release

FOI – 000134: NP33922 Ranibizumab Tender

Published on 27 June 2022

Date received – 06 June 2022 | Date responded – 27 June 2022

Request

Subject: Tender: Freedom of Information request: NP33922 Ranibizumab (the "Tender")

Teva UK Limited recently took part in the Tender via the Bravo system; we understand that Novartis also participated in the Tender and may have made comments about Teva during the process.

We kindly request access to:

  1. Any and all communications (such as emails) by Novartis in respect of the Tender in which Teva is identified in the content;
  2. Any and all memorandums and / or call logs with Novartis in which Teva is identified therein; and
  3. Any and all Tender documents whereby Novartis provides comments and / or edits thereon and which identify Teva therein.

I understand that these documents may be redacted as appropriate.

Response

I refer to your freedom of information request that we received on 06 June 2022. I can advise you that we have now completed the search of our records and can provide you with the following information:

Subject: Tender: Freedom of Information request: NP33922 Ranibizumab (the "Tender")

Teva UK Limited recently took part in the Tender via the Bravo system; we understand that Novartis also participated in the Tender and may have made comments about Teva during the process. I understand that these documents may be redacted as appropriate.

We kindly request access to:

1. Any and all communications (such as emails) by Novartis in respect of the Tender in which Teva is identified in the content;

Under Section 17 of the Freedom of Information Scotland Act an organisation does not require to provide information if it does not hold that information. NHS National Services Scotland has completed a search of our records and hold no information for Novartis in respect of Teva. Therefore, we are unable to provide you with any communications (such as emails).

2. Any and all memorandums and / or call logs with Novartis in which Teva is identified therein; and

Under Section 17 of the Freedom of Information Scotland Act an organisation does not require to provide information if it does not hold that information. NHS National Services Scotland has completed a search of our records and hold no information for Novartis in respect of Teva. Therefore, we are unable to provide you with any memorandums and/or call logs.

3. Any and all Tender documents whereby Novartis provides comments and / or edits thereon and which identify Teva therein.

Under Section 17 of the Freedom of Information Scotland Act an organisation does not require to provide information if it does not hold that information. NHS National Services Scotland has completed a search of our records and hold no information for Novartis in respect of Teva. Therefore, we are unable to provide you with any Tender documents.

I trust you will find the information of assistance and if you require any further information please do not hesitate to contact us.

If you are unhappy with any aspect of how we have dealt with your request you can make representations to us asking us to review the handling of your request.

If you require any further information please contact Associate Director Information Security & Governance, within 40 working days of the date of this correspondence.

Contact

Address

NHS National Services Scotland
Headquarters
Gyle Square
1 South Gyle Crescent
Edinburgh
EH12 9EB

If after a review you are still unhappy, you also have the right to apply to the Scottish Information Commissioner, who can be contacted at Kinburn Castle, St Andrews, Fife, KY16 9DS, or via their application form.

National Services Scotland (NSS) is committed to publishing all information released in response to Freedom of Information requests. You can view all FOI responses within our FOI Publications repository.